Triox Pharmchem Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.40 M
- Revenue Growth -0.76%
- Profit Growth 156.92%
- Ebitda 118.70%
- Net Worth 7.52%
- Total Assets -23.22%
About Triox Pharmchem
Triox Pharmchem Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 February 2008 and has a history of 16 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.40 M.
Digvir Jadeja and Sameep Mehta serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2008PTC178855
-
Company No.
178855
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Feb 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Triox Pharmchem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Digvir Jadeja
|
Director | 13-Feb-2008 | Current |
|
Sameep Mehta
|
Director | 13-Feb-2008 | Current |
Financial Performance of Triox Pharmchem.
Triox Pharmchem Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.76% decrease. The company also saw a substantial improvement in profitability, with a 156.92% increase in profit. The company's net worth moved up by a moderate rise of 7.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Triox Pharmchem?
In 2021, Triox Pharmchem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Analytica Labchem Private LimitedDigvir Jadeja is a mutual person
Charges (Loans)
₹2.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2021 | Others | ₹2.40 M | Open |
How Many Employees Work at Triox Pharmchem?
Unlock and access historical data on people associated with Triox Pharmchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Triox Pharmchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triox Pharmchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
